摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

plagiochin E

中文名称
——
中文别名
——
英文名称
plagiochin E
英文别名
PLE;2-oxapentacyclo[22.2.2.13,7.010,15.016,21]nonacosa-1(26),3,5,7(29),10(15),11,13,16(21),17,19,24,27-dodecaene-4,12,17-triol
plagiochin E化学式
CAS
——
化学式
C28H24O4
mdl
——
分子量
424.496
InChiKey
NSCJOIQNVRCXIF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.5
  • 重原子数:
    32
  • 可旋转键数:
    0
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    69.9
  • 氢给体数:
    3
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    plagiochin EN-溴代丁二酰亚胺(NBS) 作用下, 以 乙腈 为溶剂, 反应 12.0h, 以50%的产率得到18-Bromo-2-oxapentacyclo[22.2.2.13,7.010,15.016,21]nonacosa-1(26),3,5,7(29),10(15),11,13,16(21),17,19,24,27-dodecaene-4,12,17-triol
    参考文献:
    名称:
    Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents
    摘要:
    Based on the core skeleton of the total synthesized bisbibenzyl marchantin C, riccardin D and plagiochin E, a series of brominated and aminomethylated derivatives of above three bisbibenzyls have been synthesized and their cytotoxic activity against KB, MCF-7 and PC3 cell lines has been preliminary evaluated. The bio-test results revealed that the brominated derivatives 21, 22, 24, 25 and 28 exhibited excellent antiproliferative activity, with IC50 value lower than their parent compounds. As a most potent microtubule depolymerization agent, compound 28 was found to arrest cells at the G(2)/M phase of the cell cycle as determined by the flow cytometry assay in PC3 cell line. The remarkable biological profile and novel structure of these bisbibenzyl derivatives make them possible as promising candidates for clinical development as chemotherapeutic agents. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.02.004
  • 作为产物:
    描述:
    (2-甲酰基-6-甲氧基苯基)三氟甲磺酸酯盐酸四(三苯基膦)钯18-冠醚-6 、 5%-palladium/activated carbon 、 氢气三溴化硼四氯化钛 、 sodium carbonate 、 potassium carbonate三乙胺 作用下, 以 四氢呋喃乙醇二氯甲烷乙酸乙酯甲苯 为溶剂, -40.0~20.0 ℃ 、300.01 kPa 条件下, 反应 130.0h, 生成 plagiochin E
    参考文献:
    名称:
    Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents
    摘要:
    Based on the core skeleton of the total synthesized bisbibenzyl marchantin C, riccardin D and plagiochin E, a series of brominated and aminomethylated derivatives of above three bisbibenzyls have been synthesized and their cytotoxic activity against KB, MCF-7 and PC3 cell lines has been preliminary evaluated. The bio-test results revealed that the brominated derivatives 21, 22, 24, 25 and 28 exhibited excellent antiproliferative activity, with IC50 value lower than their parent compounds. As a most potent microtubule depolymerization agent, compound 28 was found to arrest cells at the G(2)/M phase of the cell cycle as determined by the flow cytometry assay in PC3 cell line. The remarkable biological profile and novel structure of these bisbibenzyl derivatives make them possible as promising candidates for clinical development as chemotherapeutic agents. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.02.004
点击查看最新优质反应信息

文献信息

  • A Synthesis-Driven Structure Revision of ‘Plagiochin E’, a Highly Bioactive Bisbibenzyl
    作者:Andreas Speicher、Matthias Groh、Josef Zapp、Anu Schaumlöffel、Michael Knauer、Gerhard Bringmann
    DOI:10.1055/s-0029-1217510
    日期:2009.7
    from Marchantia polymorpha, a liverwort. The total synthesis of the proposed structure for plagiochin E and of two structurally and biosynthetically related bisbibenzyls and comparison of the NMR data of the synthetic compounds with those of the isolated bisbibenzyls necessitates a structure revision for plagiochin E. Exemplarily for this metabolite, the stereostructure was investigated, by racemate
    最近,一种名为 plagiochin E 的双苄基显示出显着的抗真菌和抗肿瘤活性,从地钱地衣中分离出来。plagiochin E 和两种结构和生物合成相关的双苄基的拟议结构的全合成以及合成化合物的 NMR 数据与分离的双苄基的 NMR 数据的比较需要对 plagiochin E 进行结构修正。 例如,对于这种代谢物,立体结构是通过对手性 Lux Cellulose-1 相的外消旋体拆分进行研究,使用 HPLC-CD 偶联和量子化学 CD 计算,清楚地将 P 构型分配给较快的对映体,将 M 构型分配给较慢的对映体。
  • Syntheses of Macrocyclic Bis(bibenzyl) Compounds Derived from Perrottetin E
    作者:Andreas Speicher、Matthias Groh、Markus Hennrich、Anh-Minh Huynh
    DOI:10.1002/ejoc.201001023
    日期:2010.12
    Macrocyclic bis(bibenzyl) compounds are natural products from liverworts and are of growing interest due to recent reports on new isolated compounds and on their remarkable biological activities. We report here on a flexible and general approach to the total set of nine bis(bibenzyl) compounds of the riccardin and plagiochin type derived from perrottetin E. The structures were confirmed through their
    大环双(联苄)化合物是来自苔类植物的天然产物,由于最近关于新的分离化合物及其显着生物活性的报道,人们越来越感兴趣。我们在此报告了对源自 perrottetin E 的 riccardin 和 plagiochin 类型的九种双(联苄基)化合物的总集合的灵活和通用方法。 通过光谱数据确认了结构,并与分离产品的数据进行了仔细比较排除芳烃连接和替代模式中的任何错误。
  • Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents
    作者:Juan Jiang、Bin Sun、Yan-yan Wang、Min Cui、Li Zhang、Chang-zhi Cui、Yan-feng Wang、Xi-gong Liu、Hong-xiang Lou
    DOI:10.1016/j.bmc.2012.02.004
    日期:2012.4
    Based on the core skeleton of the total synthesized bisbibenzyl marchantin C, riccardin D and plagiochin E, a series of brominated and aminomethylated derivatives of above three bisbibenzyls have been synthesized and their cytotoxic activity against KB, MCF-7 and PC3 cell lines has been preliminary evaluated. The bio-test results revealed that the brominated derivatives 21, 22, 24, 25 and 28 exhibited excellent antiproliferative activity, with IC50 value lower than their parent compounds. As a most potent microtubule depolymerization agent, compound 28 was found to arrest cells at the G(2)/M phase of the cell cycle as determined by the flow cytometry assay in PC3 cell line. The remarkable biological profile and novel structure of these bisbibenzyl derivatives make them possible as promising candidates for clinical development as chemotherapeutic agents. (C) 2012 Elsevier Ltd. All rights reserved.
查看更多